Brazil grants full approval to Pfizer’s COVID-19 vaccine

SAO PAULO (Reuters) – Brazilian health regulator Anvisa has granted full approval to a COVID-19 vaccine developed by Pfizer Inc and Germany’s BioNTech SE, the agency said in a Tuesday statement.


By Eduardo Simões via Reuters


Read full article here

Share This

Chamber Updates Stay connected with Chamber activities